We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Vicotex

Download Mobile App




Study to Identify Genetic Makeup of Autism

By Biotechdaily staff writers
Posted on 16 Jan 2004
A genome-wide discovery effort aimed at identifying the key genetic components of autism and autism spectrum disorders (ASDs) has been announced by deCODE genetics (Reykjavik, Iceland). More...
The study is being funded by a U.S.$2.8 million grant from the Simons Foundation (NY, NY, USA).

Autism and ASDs run in families, but the identification of the specific inherited causes may provide valuable insights into the neurologic dysfunctions they evoke. Knowledge of the biology of these disorders may in turn clarify the role of environmental factors and contribute to the development of new methods of diagnosis and treatment. The deCODE study aims to include several hundred individuals with autism and ASDs and several thousand of their relatives, which will enable researchers to identify key genes linked to these disorders and pinpoint which elements of these complex phenotypes are inherited.

The deCODE study team is working with a number of Icelandic organizations. Questionnaires will be given to family members that are designed to capture subtle behavioral and personality traits that may constitute important components of autism and ASDs. Although the number of people diagnosed with autism and ASDs has risen rapidly in recent years, since so little is known about the causes of these disorders it is unclear whether this is due to better diagnosis or to an actual prevalence of the phenotype.

"Our discoveries and other neurologic and behavioral disorders like schizophrenia, anxiety, and depression demonstrate that our population approach has the power to pull out major genes even in the most complex disorders, the basic biology of which is little understood,” said Kari Stefansson, CEO of deCODE. "I am confident that we will succeed in autism as well, and we and our collaborators are very grateful to the Simons Foundation for their support for this project.”



Related Links:
DeCODE genetics

Platinum Member
Automated Coagulation Analyzer
Hemolumi H6
New
Gold Member
Platelet Function Analyzer
PL-12
Pipette Calibration System
Artel PCS®
New
Microbiology Laboratory Automation Solution
BD Kiestra™ ReadA+BarcodA
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: Alzheimer’s pathology can start 15 to 20 years before symptoms, and validated tools that reach patients earlier help pave the way for earlier detection. (Image Credit: Adobe Stock)

Alzheimer’s Blood Test Becomes First FDA-Cleared Option for Adults as Young as 40

C2N Diagnostics’ PrecivityAD2 blood test was cleared by the U.S. Food and Drug Administration (FDA) on August 20, 2026, for adults as young as 40 who are experiencing signs of cognitive impairment, according... Read more

Pathology

view channel
Image: Adrenal gland tumor stained with hematoxylin and eosin (top) and CYP11B2 (bottom) (Photo courtesy of Christofer Juhlin)

Simple Immunohistochemical Size Ratio Improves Classification of Primary Aldosteronism

Primary aldosteronism is a common but underdiagnosed cause of hypertension, in which excess aldosterone promotes salt retention and raises blood pressure. Identifying the dominant source of hormone overproduction... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.